Latest EDGAR 4 filed on 2026-07-02, report date 2026-07-01: Monson Jonathan / BOSTON SCIENTIFIC CORP reports ownership changes; on 07/01/2026; in Common Stock; including 2,087 shares at 0.0000 per share; 40,073 shares at 43.06 per share; 1,010 shares at 43.06 per share; 1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. 2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant. /s/ Susan Thompson, Attorney-in-Fact 07/02/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)
Stock detail
Boston Scientific (BSX) stock price, chart, and key data
View Boston Scientific stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Boston Scientific
BSX · XNYS
+$1.15 (+2.67%) past day
$44.18
Overnight $44.15 (-0.05%)
Key metrics
Financials
Quarterly revenue, profitability, and balance-sheet snapshot
Day range
$42.81 - $44.68
Close price
$43.58
Market cap
$64.8B
P/E ratio
49.08
About the company
Boston Scientific Corp.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Ro Khanna
democrat · House · CA-17
- Buy$15,001 / $32,501 / $50,000
#2Markwayne Mullin
republican · Executive · OK
- Buy$15,001 / $32,501 / $50,000
#3Michael McCaul
republican · House · TX-10
- Buy$1,000 / $8,000 / $15,000
#4Alan Armstrong
- Buy$1,001 / $8,001 / $15,000
#5Gilbert Cisneros
democrat · House · CA-31
- Buy$1,001 / $8,001 / $15,000
- Buy$1,001 / $8,001 / $15,000
- Sell$1,001 / $8,001 / $15,000
- Buy$1,001 / $8,001 / $15,000
#6Ro Khanna
democrat · House · CA-17
#7Rob Bresnahan
republican · House · PA-8
#8Kevin Hern
republican · House · OK-1
#9Julie Johnson
democrat · House · TX-32
#10Donald J Trump
republican · Executive
#11John McGuire
republican · House · VA-5
#12Tina Smith
democrat · Senate · MN
#13John Boozman
republican · Senate · AR
- Sell$1,001 / $8,001 / $15,000
- Sell$1,001 / $8,001 / $15,000
#14Valerie Hoyle
democrat · House · OR-4
Market action
A concise summary of the latest filing, transaction, or market-moving item.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app